Avecho plots A$11m capital raise to underpin CBD clinical trial by Steve Jones April 3, 2023April 30, 2024 Avecho Biotechnology is seeking to raise A$11 million to test its low-dose CBD for the treatment […]
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022April 29, 2024
Modern medicine: can the dominance of oil and flower be challenged? by Steve Jones October 6, 2022April 29, 2024
Avecho ‘adamant’ that S3 insomnia trial must be accepted overseas by Steve Jones May 4, 2022April 29, 2024
Avecho’s topical CBD gel shows promise in treating osteoarthritis by Martin Lane March 29, 2022April 29, 2024
Company news: Cann Global; Incannex; Creso Pharma; Rua Bioscience; Avecho; InhaleRx; Greenfern Industries; MGC Pharma by cannabiz team March 3, 2022April 29, 2024
Avecho inks licence and supply deal for US recreational market by Martin Lane February 2, 2022April 29, 2024
Avecho eyes arthritis market with Medterra tie up in the US by Martin Lane December 20, 2021April 29, 2024
Australian Rheumatology Association calls for more evidence on cannabis by Hannah Adler December 15, 2021April 29, 2024
Company news: ANTG; Avecho; Canopy Growth; Zelira/Levin Health; Neurotech; Epsilon; Creso Pharma by cannabiz team December 9, 2021April 29, 2024
